Youlife Group Inc. Announces A Strategic Partnership With Sealand Maritime Service Co., Ltd. to Build a New Talent Ecosystem for High-end Cruise Tourism Services
BEIJING, Jan. 9, 2026 /PRNewswire/ — Youlife Group Inc. (“Youlife” or the “Company”) (NASDAQ: YOUL), a leading blue-collar lifetime... Read more.
Bitmine Appoints Chief Financial Officer and Chief Operating Officer
Finance, VC and engineering veteran, Young Kim, joins dual role as CFO and COO, effective immediately Bitmine now owns 3.43% of the ETH token supply, two-thirds... Read more.
EpicQuest Education Awarded CES Speed Award for Global Branding
The Award Recognizes the Company’s Internationalization Strategy that Exports its Academic Programs and Pioneers Initiatives that Integrate AI into Higher... Read more.
MySize Inc. Advances AI Roll-Up Strategy in Retail and Fashion Through Targeted Acquisition Focus
TEL AVIV, Israel and NEW YORK, Jan. 9, 2026 /PRNewswire/ — MySize, Inc. (NASDAQ: MYSZ), a provider of AI-powered technology solutions for the global retail... Read more.
Brado and Santé Ventures Partner to Transform Patient Navigation and Engagement
Investment spurs creation of Brado AI, a dedicated technology entity focused on extending provider reach through conversational AI ST. LOUIS, Jan. 9, 2026 /PRNewswire/... Read more.
At CES 2026, The Things Industries Unveils Two Billion Dollar Impact Delivered by their Low Power IoT Platform and Products, Marking a New Era of Mature and Scalable IoT
LAS VEGAS, Jan. 9, 2026 /PRNewswire/ — The Things Industries announced today that the global economic value generated by organizations running low power IoT... Read more.
Last Chance to Exhibit: Money Expo Mexico 2026 Nears Full Capacity with Top-Tier Sponsors Onboard
MEXICO CITY, Jan. 9, 2026 /PRNewswire/ — Money Expo Mexico 2026, Latin America’s flagship event for online trading, fintech, and investment, is now 90%... Read more.
Avista Therapeutics Expands AI Gene Therapy Platform to Break Barriers in the Delivery of Genetic Medicines
PITTSBURGH, Jan. 9, 2026 /PRNewswire/ — Avista Therapeutics, a preclinical gene therapy company built on deep clinical, computational and gene therapy expertise,... Read more.
LSF12 Helix Parent, LLC Announces Change of Control Offers for Hillenbrand, Inc.’s Senior Notes
DALLAS and NEW YORK and LONDON and TOKYO, Jan. 9, 2026 /PRNewswire/ — LSF12 Helix Parent, LLC (“Parent”), an affiliate of certain investment funds... Read more.
GRIN Therapeutics Announces First Patient Dosed in Global Phase 3 Beeline Trial of Investigational Radiprodil for GRIN-Related Neurodevelopmental Disorder
NEW YORK, Jan. 9, 2026 /PRNewswire/ — GRIN Therapeutics, Inc., a leader in the development of targeted disease-specific therapies for serious neurodevelopmental... Read more.